Jump to ContentJump to Main Navigation
Show Summary Details

Drug Metabolism and Personalized Therapy

Official journal of the European Society of Pharmacogenomics and Personalised Therapy

Editor-in-Chief: Llerena, Adrián

Editorial Board: Benjeddou, Mongi / Chen, Bing / Dahl, Marja-Liisa / Devinsky, Ferdinand / Hirata, Rosario / Hubacek, Jaroslav A. / Ingelman-Sundberg, Magnus / Maitland-van der Zee, Anke-Hilse / Manolopoulos, Vangelis G. / Marc, Janja / Melichar, Bohuslav / Meyer, Urs A. / Nair, Sujit / Nofziger, Charity / Peiro, Ana / Sadee, Wolfgang / Salazar, Luis A. / Simmaco, Maurizio / Turpeinen, Miia / Schaik, Ron / Shin, Jae-Gook / Visvikis-Siest, Sophie / Zanger, Ulrich M.

CiteScore 2018: 1.01

SCImago Journal Rank (SJR) 2018: 0.277
Source Normalized Impact per Paper (SNIP) 2018: 0.446

    99,00 € / $149.00 / £80.00*

    See all formats and pricing
    More options …
    Select Volume and Issue



    Your benefits:
    • Comprehensive approach to drug metabolism research
    • State-of-the-art research results
    • Renowned editorial board
    • High quality peer-review

    Drug Metabolism and Personalized Therapy is the official journal of the European Society of Pharmacogenomics and Personalised Therapy (ESPT).

    Aims and Scope

    Drug Metabolism and Personalized Therapy (DMPT) is a peer-reviewed journal, and is abstracted/indexed in relevant major Abstracting Services. It provides up-to-date research articles, reviews and opinion papers in the wide field of drug metabolism research, covering established, new and potential drugs, environmentally toxic chemicals, the mechanisms by which drugs may interact with each other and with biological systems, and the pharmacological and toxicological consequences of these interactions and drug metabolism and excretion.

    • drug metabolizing enzymes
    • pharmacogenetics and pharmacogenomics
    • biochemical pharmacology
    • molecular pathology
    • clinical pharmacology
    • pharmacokinetics and drug-drug interactions
    • immunopharmacology
    • neuropsychopharmacology

    Article formats
    Research Articles, Reviews and Mini Reviews, Opinion Papers, Short Communications, letters to the Editor, Case Reports, Editorials


    Type of Publication:

    researchers and professionals in the field of pharmacology, basic scientists, translational researchers, industry scientists and professionals in the field of pharmacology

    Submission of Manuscripts

    Instructions for Authors

    You can easily submit your manuscript online. Simply go to http://mc.manuscriptcentral.com/dmpt and you will be guided through the whole submission and publishing process.

    Your benefits of publishing with us
    • Rapid publication times
    • No submission fee
    • Free color illustrations
    • Professional sales and marketing support
    • Optional open access publication
    • Accepted papers will be published online first as DOI-citable, forward-linked articles for quickest possible visibility for the scientific community
    • Every article easily discoverable because of SEO and comprehensive abstracting and indexing services
    • Convenient citation tracking via e-mail alert
    • Secure archiving by De Gruyter and the independent archiving service Portico
    • Professional sales and marketing support
    Submission process
    • Submission of your paper via our submission management tool following the Information for Authors (you will be guided through every step of the submission process)
    • Single-blind peer review process
    • A decision on your paper is aspired within 3-5 weeks
    • Accepted articles are published online ahead of print approx. 3–4 weeks after acceptance
    Please note
    • Manuscripts must be written in clear and concise English
    • Before submitting your article please have a look at our Publication Ethics Statement and our copyright agreement
    • Once your article is accepted you have the option to publish it open access
    • Our repository policy repository policy allows you to distribute 30 PDF copies of your published article to colleagues (the PDF has to include the information that it is an author's copy). Please also feel free to distribute the link to the online abstract.
    • If you have any general questions please visit our FAQ page for authors.
    • For more detailed information contact the DMPT Editorial Office at DMPT.editorial@degruyter.com

    Hybrid Open Access

    For complete details on hybrid open access publishing at De Gruyter please see: https://www.degruyter.com/page/560

    Effective 1st January 2016, authors from an institution affiliated with either the Association of Dutch Universities (VSNU), the Consortium of Swiss Academic Libraries or some UK libraries participating in the Jisc Collections SMP may publish primary research and review articles open access in any of De Gruyter's OnlineOpen journals at a discount of 90% of the APC price. For more information and to confirm whether your institution is eligible please see the following:

    The Netherlands: https://www.degruyter.com/page/1461
    The UK: https://www.degruyter.com/page/1462
    Switzerland: https://www.degruyter.com/page/1463

    More ...

    Name Changes

    Founded in 1981 until 2014: Drug Metabolism and Drug Interactions

    From 2015 onwards: Drug Metabolism and Personalized Therapy

    Other publications in the field

    Abstracting & Indexing

    Drug Metabolism and Personalized Therapy is covered by the following services:

    • Baidu Scholar
    • Biobase
    • Case
    • Chemical Abstracts Service (CAS) - CAplus
    • Chemical Abstracts Service (CAS) - SciFinder
    • CNKI Scholar (China National Knowledge Infrastructure)
    • CNPIEC - cnpLINKer
    • Dimensions
    • EBSCO (relevant databases)
    • EBSCO Discovery Service
    • Embase
    • Genamics JournalSeek
    • Google Scholar
    • Japan Science and Technology Agency (JST)
    • J-Gate
    • JournalTOCs
    • KESLI-NDSL (Korean National Discovery for Science Leaders)
    • Medline
    • Meta
    • Microsoft Academic
    • MyScienceWork
    • Naviga (Softweco)
    • Norwegian Register for Scientific Journals, Series and Publishers
    • Primo Central (ExLibris)
    • ProQuest (relevant databases)
    • Publons
    • PubMed
    • PubsHub
    • QOAM (Quality Open Access Market)
    • ReadCube
    • Reaxys
    • SCImago (SJR)
    • SCOPUS
    • Semantic Scholar
    • Summon (ProQuest)
    • TDNet
    • TEMA Technik und Management
    • Text Mining
    • Ulrich's Periodicals Directory/ulrichsweb
    • WanFang Data
    • Web of Science - Biological Abstracts
    • Web of Science - BIOSIS Previews
    • Web of Science - International Pharmaceutical Abstracts
    • Web of Science - Prous Science Integrity
    • WorldCat (OCLC)

    Editorial Information

    Adrián LLerena
    CICAB Clinical Research Center, Extremadura University Hospital, Badajoz, Spain

    Associate Editor
    Vangelis G. Manolopoulos, Dept. of Pharmacology, Democritus University of Thrace Medical School, Alexandroupolis, Greece

    Editorial Board
    Mongi Benjeddou, Dept. of Biotechnology, University of the Western Cape, Cape Town, South Africa
    Bing Chen, Shanghai, Dept. of Laboratory Medicine, Jiaotong University, Shanghai, P.R. China
    Marja-Liisa Dahl, Dept. of Laboratory Medicine, Karolinska University Hospital, Stockholm, Sweden
    Ferdinand Devinsky, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia
    Rosario D.C. Hirata, Clinical and Toxicological Analysis, University of Sao Paulo, Sao Paulo, Brazil
    Jaroslav Hubacek, Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine
    Magnus Ingelman-Sundberg, Dept. of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
    Anke Hilse Maitland van der Zee, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands
    Janja Marc, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
    Bohuslav Melichar, Dept. of Oncology, Palacky Unversity Medical School, Hradec Králové, Czech Republic
    Urs A. Meyer, Dept. of Pharmacology, Biocenter of the University of Basel, Basel, Switzerland
    Sujit Nair, Pharmaceutical Sciences, Amrita University, Kerala, India
    Charity Nofziger, Insitute of Pharmacology and Toxicology, Paracelsus Medical University, Salzburg, Austria
    Ana Peiró, University General Hospital of Alicante, Alicante, Spain
    Wolfgang Sadee, Dept. of Pharmacology, The Ohio State University, Columbus, OH, USA
    Luis A. Salazar, Ciencias Basicas, Universidad de La Frontera, Temuco, Chile
    Jae-Gook Shin, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, South Korea
    Maurizio Simmaco, Dept. of Neurosciences, Faculty of Medicine & Psychology, Sapienza University of Rome, Rome, Italy
    Miia Turpeinen, Dept. of Pharmacology and Toxicology, University of Oulu, Oulu, Finland
    Ron H.N. van Schaik, Dept. of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands
    Sophie Visvikis-Siest, INSERM U525, University of Lorraine, Nancy, France
    Ulrich M. Zanger, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany

    Editorial Office
    Heike Jahnke, Journal Editor
    Walter de Gruyter GmbH
    Genthiner Str. 13, 10785 Berlin, Germany
    Tel. +49-30-26005-220; Fax: +49-30-26005-184; E-mail: dmpt.editorial@degruyter.com

    Comments (2)

    Please log in or register to comment.
    Log in
    • Maximum <a href="http://www.ddtwc.com/" rel="follow">Drug Metabolism</a> takes place in the liver, but other organs also may play a role (for example, the kidneys, intestine, etc.). The cytochrome P450 enzymes are a cluster of enzymes in the liver that are in charge for the metabolism of most drugs.

      posted by: Drug Discovery on 2014-11-17 08:39 AM (Europe/Berlin)

    • I found this journal of immense importance http://globalbiotechcongress.com/

      posted by: Plant and Environment on 2014-12-02 12:33 PM (Europe/Berlin)